Gustafson DL - Search Results

1

Inhibition of human neutrophil reactive oxygen species production and p67phox translocation by cigarette smoke extract.

Dunn JS, Freed BM, Gustafson DL, Stringer KA. Dunn JS, et al. Among authors: gustafson dl. Atherosclerosis. 2005 Apr;179(2):261-7. doi: 10.1016/j.atherosclerosis.2004.11.011. Epub 2005 Jan 19. Atherosclerosis. 2005. PMID: 15777540

2

Administration of exogenous tissue plasminogen activator reduces oedema in mice lacking the tissue plasminogen activator gene.

Stringer KA, Dunn JS, Gustafson DL. Stringer KA, et al. Among authors: gustafson dl. Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):327-30. doi: 10.1111/j.1440-1681.2004.03999.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15191406

3

Particulate phase cigarette smoke increases MnSOD, NQO1, and CINC-1 in rat lungs.

Stringer KA, Freed BM, Dunn JS, Sayers S, Gustafson DL, Flores SC. Stringer KA, et al. Among authors: gustafson dl. Free Radic Biol Med. 2004 Nov 15;37(10):1527-33. doi: 10.1016/j.freeradbiomed.2004.08.008. Free Radic Biol Med. 2004. PMID: 15477004

4

NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.

Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, Ross D. Siegel D, et al. Among authors: gustafson dl. Mol Pharmacol. 2004 May;65(5):1238-47. doi: 10.1124/mol.65.5.1238. Mol Pharmacol. 2004. PMID: 15102952

5

Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo.

Gustafson DL, Siegel D, Rastatter JC, Merz AL, Parpal JC, Kepa JK, Ross D, Long ME. Gustafson DL, et al. J Pharmacol Exp Ther. 2003 Jun;305(3):1079-86. doi: 10.1124/jpet.103.050070. Epub 2003 Mar 20. J Pharmacol Exp Ther. 2003. PMID: 12649308

6

Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.

Guo W, Reigan P, Siegel D, Zirrolli J, Gustafson D, Ross D. Guo W, et al. Cancer Res. 2005 Nov 1;65(21):10006-15. doi: 10.1158/0008-5472.CAN-05-2029. Cancer Res. 2005. PMID: 16267026

7

Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.

Zerbe LK, Dwyer-Nield LD, Fritz JM, Redente EF, Shroyer RJ, Conklin E, Kane S, Tucker C, Eckhardt SG, Gustafson DL, Iwata KK, Malkinson AM. Zerbe LK, et al. Among authors: gustafson dl. Cancer Chemother Pharmacol. 2008 Sep;62(4):605-20. doi: 10.1007/s00280-007-0644-z. Epub 2007 Nov 21. Cancer Chemother Pharmacol. 2008. PMID: 18030469

8

P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing.

Gustafson DL, Long ME, Bradshaw EL, Merz AL, Kerzic PJ. Gustafson DL, et al. Cancer Chemother Pharmacol. 2005 Sep;56(3):248-54. doi: 10.1007/s00280-004-0988-6. Epub 2005 Apr 27. Cancer Chemother Pharmacol. 2005. PMID: 15856231

9

Tissue distribution and metabolism of the tyrosine kinase inhibitor ZD6474 (Zactima) in tumor-bearing nude mice following oral dosing.

Gustafson DL, Bradshaw-Pierce EL, Merz AL, Zirrolli JA. Gustafson DL, et al. J Pharmacol Exp Ther. 2006 Aug;318(2):872-80. doi: 10.1124/jpet.106.102376. Epub 2006 Apr 27. J Pharmacol Exp Ther. 2006. PMID: 16644900

10

The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins.

Guo W, Reigan P, Siegel D, Zirrolli J, Gustafson D, Ross D. Guo W, et al. Mol Pharmacol. 2006 Oct;70(4):1194-203. doi: 10.1124/mol.106.025643. Epub 2006 Jul 6. Mol Pharmacol. 2006. PMID: 16825487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page